Prothena Corporation (NASDAQ:PRTA)

CAPS Rating: 3 out of 5

PRTA News and Commentary

Caps

How do you think PRTA will perform against the market?

Add Stock to CAPS Watchlist

All Players

31 Outperform
7 Underperform
 

All-Star Players

11 Outperform
4 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top PRTA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.83)
Submitted December 06, 2014

Prothena doesn't seem to have impressed the street much with their recent announcement of positive interim data from the phase I/II trial of NEOD001 anti-amyloid mAb for amyloid light chain (AL) amyloidosis. The company reported a 50% cardiac… More

zzlangerhans (99.83)
Submitted October 22, 2013

Prothena has a healthy market cap of 450M despite a very immature pipeline and a questionable therapeutic platform. The company purports to treat amyloidosis and Parkinson's disease with monoclonal antibodies against abnormally folded proteins, but… More

PRTA VS S&P 500 (SPY)

PRTA Summary

Recent Community Commentary

Read the most recent pitches from players about PRTA.

Recs

0
Member Avatar usubanas (99.78) Submitted: 9/29/2017 10:20:54 AM : Outperform Start Price: $64.24 PRTA Score: -8.14

Promising Parkinson's trial

Recs

0
Member Avatar nakrak (< 20) Submitted: 4/7/2015 2:27:34 PM : Outperform Start Price: $38.12 PRTA Score: +35.64

Good pipeline in addition to present outlook of Parkinsons Diseqse

Leaderboard

Find the members with the highest scoring picks in PRTA.

Score Leader

TrackWedbush

TrackWedbush (86.93) Score: +371.67

The Score Leader is the player with the highest score across all their picks in PRTA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
maven12 85.57 6/19/2013 Outperform 5Y $13.10 +360.69% +54.64% +306.05 0 Comment
foggs1 74.23 12/8/2014 Outperform 5Y $19.98 +202.10% +23.23% +178.88 0 Comment
tarik500 85.04 7/15/2014 Outperform 5Y $19.79 +205.00% +29.66% +175.34 0 Comment
efarev 98.99 1/12/2015 Outperform 5Y $21.02 +187.16% +25.84% +161.31 0 Comment
odocoileus 31.40 12/22/2014 Outperform 5Y $21.62 +179.19% +23.69% +155.50 0 Comment
gunda7907 < 20 5/22/2014 Outperform 5Y $20.99 +187.57% +35.17% +152.39 0 Comment
BlueLens 50.49 3/9/2015 Outperform 3Y $26.08 +131.44% +23.10% +108.35 0 Comment
notsorandomwalk 47.96 11/4/2013 Outperform 5Y $24.60 +145.37% +44.79% +100.57 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. zojo360 84.32 2/24/2015 2/19/2016 Outperform 1Y $28.13 +114.58% +21.13% +93.45 0 Comment
best2015 < 20 3/19/2015 Outperform 5Y $28.49 +111.86% +21.79% +90.07 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 84.92 3/20/2015 Outperform 3W $38.66 +56.13% +21.53% +34.60 0 Comment
TrackWedbush 86.93 6/27/2013 Outperform NS $11.38 +430.40% +58.73% +371.67 0 Comment

Featured Broker Partners